Key facts
- It has raised $10.0M across 1 recorded rounds; the latest was Early Stage VC ($7.7M) in Jan 2025.
- Notable investors include US National Science Foundation, Impact Assets, Impact Foundation, Catalytic Impact Foundation, WARF Ventures — 17 tracked in total.
- Madison Scientific has filed 2 Form Ds with the SEC, most recently Apr 2025 ($7.7M sold to 69 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Madison Scientific
Funding rounds
1 roundsAbout Madison Scientific
Developer of an implantable medical device designed to manage hydrocephalus by monitoring and regulating cerebrospinal fluid drainage. The company's device integrates an intracranial pressure sensor, communication modules, and a valve system to adjust fluid flow in real-time, enabling healthcare providers to maintain optimal intracranial pressure levels, reduce shunt failure rates, and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2020
- Employees
- 6
- Website
- madsci.com/
- Ownership
- Privately Held (backing)
Madison Scientific doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Madison Scientific shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Madison Scientific in its N-PORT filings yet. We sweep new filings monthly.